Pembrolizumab/Vibostolimab
7684A-003
Phase 3 mab completed
Quick answer
Pembrolizumab/Vibostolimab for Lung Neoplasms is a Phase 3 program (mab) at Merck KGaA, Darmstadt, Germany with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck KGaA, Darmstadt, Germany
- Indication
- Lung Neoplasms
- Phase
- Phase 3
- Modality
- mab
- Status
- completed